Amprion Newsroom
Recent media coverage and announcements.
News Article
Neurology Live
Feasibility and Scalability of Amprion's Assay for Synucleinopathy Diagnosis: Russ Lebovitz MD PhD
1/24/2025
Read MoreNews Article
Medical Product Outsourcing
Getting to the Point of In-Vitro Diagnostics
4/29/2025
Read MoreNews Article
Today's Clinical Lab
New Biomarkers for Better Neurodegenerative Disease Diagnostics and Treatments
11/14/2024
Read MoreNews Article
Neurology Live
Revolutionizing Dementia Research With Synuclein Biomarker Tests
8/31/2023
Read MoreNews Article
Washington Post
Parkinson's is often misdiagnosed. New tests may change that.
10/10/2024
Read MoreNews Article
Precision Medicine Online
NIH Researchers to Use Amprion CSF Test in Dementia Biomarker Validation Study
8/24/2023
Read MoreNews Article
Fierce Biotech
New test detects Parkinson's biomarker before movement symptoms start
4/18/2023
Read MoreNews Article
Everyday Health
Lab Test May Detect Parkinson's Disease Even Before Symptoms Appear
4/17/2023
Read MoreNews Article
Parkinson's News Today
FDA letter supports use of new alpha-synuclein assay in trials
9/9/2024
Read MoreNews Article
360Dx
FDA Letter of Support Could Boost Use of Parkinson's Biomarker in Clinical Trials
9/19/2024
Read MoreNews Article
Clinical Lab Products
FDA Issues Letter of Support for Alpha-Synuclein Seed Amplification Assay
9/5/2024
Read MoreNews Article
Endpoints
Exclusive: A small San Diego biotech wants to change how Parkinson's disease is diagnosed
10/8/2024
Read MoreNews Article
HCP Live
Changes in the Diagnostic Process of Alzheimer Disease: A New Era of Blood-Based Approaches
12/8/2023
Read MoreNews Article
PharmaVoice
As new Alzheimer's biomarkers come into play here's where the money is going
10/17/2024
Read More
Get in the Know
Bring biological certainty to your diagnosis with Amprion's SAAmplify-ɑSYN test. Order your shipping kits today and help move your patient beyond a probable diagnosis.
